and mental anguish," though it was later reduced to $680,000. In the second portion of the bifurcated trial, the plaintiffs sought to prove that the companies knew and deliberately disregarded evidence that Risperidone could lead to gynecomastia in young males, and nonetheless promoted the medication off-label and released the medication into the open market for prescription and use by patients without disclosing the side effects. The jury found for the plaintiffs in the second portion of the trial and awarded $8 billion in punitive damages. The amount was later reduced to $6.8 million by Judge Kenneth Powell Jr. Etymology The term comes from Greek gyné (stem gynaik-) 'female' and mastós 'breast'. See also Breast hypertrophy Male bra Male lactation Mammoplasia References Explanatory notes Citations External links Andrology Breast diseases Endocrine diseases Medical conditions related to obesity